为粘膜粘合和生物交互性脂基药物递送系统设计硫化聚乙氧化表面活性剂:分子设计,性能和转化潜力
Ahmed Raza Hashmi1, Farwa Zahra2, Ram Narayanan Ravi3
1School of Pharmacy, Monash University Malaysia, Bandar Sunway, Subang Jaya, Selangor, Malaysia.
Colloids and surfaces. B, Biointerfaces
|February 27, 2026
概括
化表面活性剂通过与体内的粘素形成键来增强药物输送. 本综述探讨了它们的化学成分,在基于脂质的系统中的应用,以及先进的粘膜技术的潜力.
科学领域:
- 生物材料科学 生物材料科学
- 药品制造 药品制造 药品制造
- 药物运输 药物运输 药物运输
背景情况:
- 化聚乙化表面活性剂通过与粘素的共价二硫化键形成,提供增强的粘膜粘附性.
- 粘膜粘合受醇pKa,粘膜氧化还原状态和粘膜氨酸可访问性等因素的影响.
研究的目的:
- 为了提供一个全面的审查在药物输送中硫化表面活性剂.
- 阐明这些先进的辅助剂的结构功能关系和应用.
主要方法:
- 对粘膜壁垒,粘膜粘合原理和硫化表面活性剂相互作用的文献进行系统审查.
- 讨论硫化表面活性剂的合成,表征和定量.
- 对融入基于脂质的药物输送系统的分析.
主要成果:
- 化表面活性剂在改善粘膜内存时间和药物递送效率方面具有显著的潜力.
- 它们的性能与与粘素和配方设计的生化相互作用密切相关.
- 将其整合到脂质纳米颗粒,纳米乳液和自我乳化系统中显示出有希望的结果.
结论:
- 化聚乙化表面活性剂代表了开发先进的粘膜粘合和生物互动药物递送系统的多功能平台.
- 对安全性,生物相容性和监管方面的进一步研究对于临床转化至关重要.
- 识别研究缺口将指导这些创新助剂的未来开发.
相关概念视频
Bioavailability Enhancement: Drug Permeability Enhancement
277
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
277
Site-Targeted Drug Delivery Systems: Polymeric Carriers
62
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
62
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
276
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
276
Modified-Release Drug Delivery Systems: Site-Targeted
51
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
51
Surface Active Agents
16
Surfactants, named for their behavior at interfaces, positively adsorb at the interfaces of two phases, reducing interfacial tension. Their versatility as emulsifiers, detergents, and foaming agents stems from this ability. Surfactants, often termed amphiphiles, share the property of amphipathy, with molecules having both hydrophilic and hydrophobic portions. The hydrophilic part is called the head, and the hydrophobic part, including an elongated alkyl substituent, forms the tail.Surfactants...
16
Bioavailability Enhancement: Drug Solubility Enhancement
365
Body:Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
365


